Eric H. Bernicker, MD

Research outputs

  1. 2019
  2. A matter of comprehensive informed consent: Short-term mortality rates with definitive treatment options in elderly stage i NSCLC

    Dalwadi, S. M., Savjani, R. R., Bernicker, E. H., Butler, E. B., Teh, B. S. & Farach, A. M., Nov 1 2019, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 42, 11, p. 851-855 5 p.

    Research output: Contribution to journalArticle

  3. Socioeconomic Factors Associated with Lack of Treatment in Early Stage Non-Small Cell Lung Cancer

    Dalwadi, S. M., Zhang, J., Bernicker, E. H., Butler, E. B., Teh, B. S. & Farach, A. M., Oct 21 2019, In : Cancer Investigation. 37, 9, p. 506-511 6 p.

    Research output: Contribution to journalArticle

  4. The Gut Microbiome Influences Responses to Programmed Death 1 Therapy in Chinese Lung Cancer Patients — the Benefits of Diversity

    Bernicker, E. H. & Quigley, E. M., Aug 1 2019, In : Journal of Thoracic Oncology. 14, 8, p. 1319-1322 4 p.

    Research output: Contribution to journalEditorial

  5. Combined blockade of activating ERBB2 mutations and ER results in synthetic lethality of ERþ/HER2 mutant breast cancer

    Croessmann, S., Formisano, L., Kinch, L. N., Gonzalez-Ericsson, P. I., Sudhan, D. R., Nagy, R. J., Mathew, A., Bernicker, E. H., Cristofanilli, M., He, J., Cutler, R. E., Lalani, A. S., Miller, V. A., Lanman, R. B., Grishin, N. V. & Arteaga, C. L., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 277-289 13 p.

    Research output: Contribution to journalArticle

  6. Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century

    Dalwadi, S. M., Lewis, G. D., Bernicker, E. H., Butler, E. B., Teh, B. S. & Farach, A. M., Jan 1 2019, (Accepted/In press) In : Clinical Lung Cancer.

    Research output: Contribution to journalArticle

  7. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma

    Schefler, A. C., Koca, E., Bernicker, E. H. & Correa, Z. M., Jan 1 2019, In : Graefe's Archive for Clinical and Experimental Ophthalmology.

    Research output: Contribution to journalReview article

  8. Update on emerging biomarkers in lung cancer

    Bernicker, E. H., Allen, T. C. & Cagle, P. T., Jan 1 2019, In : Journal of Thoracic Disease. 11, p. S81-S88

    Research output: Contribution to journalReview article

  9. What the oncologist needs from the pathologist for tyrosine kinase inhibitor therapies

    Bernicker, E. H., Jan 1 2019, In : Archives of Pathology and Laboratory Medicine. 143, 9, p. 1089-1092 4 p.

    Research output: Contribution to journalArticle

  10. 2018
  11. Correlation between programmed death receptor-1 expression in tumor-infiltrating lymphocytes and programmed death ligand-1 expression in non-small cell lung carcinoma

    Monroig-Bosque, P. D. C., Driver, B., Morales-Rosado, J. A., Deavers, M., Tacha, D., Bernicker, E., Cagle, P. T. & Miller, R. A., Nov 1 2018, In : Archives of Pathology and Laboratory Medicine. 142, 11, p. 1388-1393 6 p.

    Research output: Contribution to journalArticle

  12. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors guideline from the college of American pathologists, the international association for the study of lung cancer, and the association for molecular pathology

    Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., Kwiatkowski, D. J., Ladanyi, M., Nowak, J. A., Sholl, L., Temple-Smolkin, R., Solomon, B., Souter, L. H., Thunnissen, E., Tsao, M. S., Ventura, C. B. & 2 othersWynes, M. W. & Yatabe, Y., Mar 1 2018, In : Archives of Pathology and Laboratory Medicine. 142, 3, p. 321-346 26 p.

    Research output: Contribution to journalArticle

  13. Evaluation of the prescribing patterns, adverse effects, and drug interactions of oral chemotherapy agents in an outpatient cancer center

    Solomon, J. M., Ajewole, V. B., Schneider, A. M., Sharma, M. & Bernicker, E. H., Jan 1 2018, (Accepted/In press) In : Journal of Oncology Pharmacy Practice.

    Research output: Contribution to journalArticle

  14. Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non–Small Cell Lung Cancer

    Schrock, A. B., Welsh, A., Chung, J. H., Pavlick, D., Bernicker, E. H., Creelan, B. C., Forcier, B., Ross, J. S., Stephens, P. J., Ali, S. M., Dagogo-Jack, I., Shaw, A. T., Li, T., Ou, S. H. I. & Miller, V. A., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

    Research output: Contribution to journalArticle

  15. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors. Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., Kwiatkowski, D. J., Ladanyi, M., Nowak, J. A., Sholl, L., Temple-Smolkin, R., Solomon, B., Souter, L. H., Thunnissen, E., Tsao, M. S., Ventura, C. B. & 2 othersWynes, M. W. & Yatabe, Y., 2018, (Accepted/In press) In : Journal of Molecular Diagnostics.

    Research output: Contribution to journalArticle

  16. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors. Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., Kwiatkowski, D. J., Ladanyi, M., Nowak, J. A., Sholl, L., Temple-Smolkin, R., Solomon, B., Souter, L. H., Thunnissen, E., Tsao, M. S., Ventura, C. B. & 2 othersWynes, M. W. & Yatabe, Y., 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

    Research output: Contribution to journalArticle

  17. 2017
  18. Programmed death ligand-1 (pd-l1) expression in either tumor cells or tumor-infiltrating immune cells correlates with solid and high-grade lung adenocarcinomas

    Driver, B. R., Miller, R. A., Miller, T., Deavers, M., Gorman, B., Mody, D., Ge, Y., Barrios, R., Bernicker, E., Kim, M. & Cagle, P. T., Nov 1 2017, In : Archives of Pathology and Laboratory Medicine. 141, 11, p. 1529-1532 4 p.

    Research output: Contribution to journalArticle

  19. Biomarkers for selection of therapy for adenocarcinoma of the lung

    Bernicker, E. H., Miller, R. A. & Cagle, P. T., Apr 1 2017, In : Journal of Oncology Practice. 13, 4, p. 221-227 7 p.

    Research output: Contribution to journalReview article

  20. Practice Patterns and Outcomes in Elderly Stage I Non-Small-cell Lung Cancer: A 2004 to 2012 SEER Analysis

    Dalwadi, S. M., Szeja, S. S., Bernicker, E. H., Butler, E. B., Teh, B. S. & Farach, A. M., 2017, (Accepted/In press) In : Clinical Lung Cancer.

    Research output: Contribution to journalArticle

  21. 2016
  22. First-line immune therapy - Implications for pathologists

    Miller, R. A., Cagle, P. T. & Bernicker, E. H., Aug 1 2016, In : Archives of Pathology and Laboratory Medicine. 140, 8, p. 739-740 2 p.

    Research output: Contribution to journalArticle

  23. Chemotherapy in non-small cell lung cancer: opportunities for advancement

    Akhtari, M., Bernicker, E. H. & Teh, B. S., Jun 23 2016, In : Chinese Journal of Lung Cancer. 35, 1, p. 56 1 p.

    Research output: Contribution to journalArticle

  24. Impact of recent developments in lung cancer on the practice of pathology

    Cagle, P. T., Allen, T. C., Bernicker, E. H., Ge, Y., Haque, A. & Barrios, R., Apr 1 2016, In : Archives of Pathology and Laboratory Medicine. 140, 4, p. 322-325 4 p.

    Research output: Contribution to journalArticle

  25. Next-generation sequencing of a cohort of pulmonary large cell carcinomas reclassified by world health organization 2015 criteria

    Driver, B. R., Portier, B. P., Mody, D. R., Deavers, M., Bernicker, E. H., Kim, M. P., Teh, B. S., Santacruz, J. F., Kopas, L., Munden, R. F. & Cagle, P. T., Apr 1 2016, In : Archives of Pathology and Laboratory Medicine. 140, 4, p. 312-317 6 p.

    Research output: Contribution to journalArticle

  26. Next-generation sequencing and immunotherapy biomarkers: A medical oncology perspective

    Bernicker, E., Mar 1 2016, In : Archives of Pathology and Laboratory Medicine. 140, 3, p. 245-248 4 p.

    Research output: Contribution to journalArticle

  27. 2015
  28. Challenges to biomarker testing for PD-1/PD-L1 checkpoint inhibitors for lung cancer

    Cagle, P. T. & Bernicker, E. H., Dec 1 2015, In : Archives of Pathology and Laboratory Medicine. 139, 12, p. 1477-1478 2 p.

    Research output: Contribution to journalArticle

  29. A new immunotherapy drug creates a watershed for the surgical pathologist's role in patient care

    Cagle, P. T. & Bernicker, E. H., Nov 1 2015, In : Archives of Pathology and Laboratory Medicine. 139, 11, p. 1329-1330 2 p.

    Research output: Contribution to journalArticle

  30. Biomarker testing in non-small cell lung cancer: A clinician's perspective

    Bernicker, E. H., Apr 1 2015, In : Archives of Pathology and Laboratory Medicine. 139, 4, p. 448-450 3 p.

    Research output: Contribution to journalArticle

  31. Therapy

    Bernicker, E. H., Gaur, P., Desai, S., Teh, B. S. & Blackmon, S. H., Jan 1 2015, Diffuse Malignant Mesothelioma. Springer New York, p. 125-139 15 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  32. 2010
  33. Cardiac chloroma: Novel presentation and subsequent diagnosis with cardiac magnetic resonance imaging

    Attallah, A., Cheong, B. Y. C., Bernicker, E. H. & Wilson, J. M., Aug 13 2010, In : Texas Heart Institute Journal. 37, 2, p. 242-243 2 p.

    Research output: Contribution to journalArticle

  34. 1996
  35. Unanticipated diagnoses found at autopsy in an urban public teaching hospital

    Bernicker, E. H., Atmar, R. L., Schaffner, D. L. & Greenberg, S. B., May 1 1996, In : American Journal of the Medical Sciences. 311, 5, p. 215-220 6 p.

    Research output: Contribution to journalArticle

  36. 1994
  37. Case report: transverse myelitis associated with Epstein-Barr virus infection.

    Caldas, C., Bernicker, E. H., Nogare, A. D. & Luby, J. P., Jan 1 1994, In : American Journal of the Medical Sciences. 307, 1, p. 45-48 4 p.

    Research output: Contribution to journalArticle

  38. 1990
  39. Interim meeting report

    Bernicker, E. H., Jan 1 1990, In : Journal of the American Medical Association. 263, 5

    Research output: Contribution to journalArticle

  40. The House of God

    Shem, S. & Bernicker, E. H., Jan 1 1990, In : Journal of the American Medical Association. 264, 13

    Research output: Contribution to journalArticle

  41. 1989
  42. Photodynamic therapy triggers cytotoxic drug retained to greater degree by cancer cells.

    Bernicker, E. H., Nov 10 1989, In : Journal of the American Medical Association. 262, 18

    Research output: Contribution to journalArticle

  43. Should we legalize drugs?

    Bernicker, E. H., Apr 28 1989, In : Journal of the American Medical Association. 261, 16

    Research output: Contribution to journalArticle

  44. Yes and no

    Bernicker, E. H., Jan 1 1989, In : Journal of the American Medical Association. 262, 21

    Research output: Contribution to journalArticle

  45. 1987
  46. [2]Calcimedins: Purification and production of antibodies

    Mathew, J. K., Scully, R. R., Smith, V. L., Bernicker, E. H. & Dedman, J. R., Dec 1 1987, In : Methods in enzymology. 139, C, p. 19-30 12 p.

    Research output: Contribution to journalArticle

ID: 2284139